**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 36062-19-8 |N,N'-Diaminoguanidine Monohydrochlorid| 98% | 252-854-0 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary
edema.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Runoff from
fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation. Use with adequate ventilation.
Storage:
Keep container closed when not in use. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 36062-19-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: light beige
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 180.00 - 182.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: CH7N5.HCl
Molecular Weight: 125.56
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and
toxic fumes and gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 36062-19-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N,N'-Diaminoguanidine Monohydrochloride -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 36062-19-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 36062-19-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 36062-19-8 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
(+)-Himbacine
| 6879-74-9 |
|
Ytterbium(III) triflate hydrate, 99.9%
| 252976-51-5 |
|
Ethyl oleate, mixture of isomers, tech., 90%
| 111-62-6 |
|
Sodium hydride, 60% dispersion in mineral oil, in resealable cans
| 7646-69-7 |
|
3-(Trifluoromethyl)phenylhydrazine, tech.,, 90%
| 368-78-5 |
|
N,N'-Diaminoguanidine Monohydrochloride 98%
| 36062-19-8 |
|
Iron(III) fluoride, anhydrous, 98%
| 7783-50-8 |
|
2-Mercaptobenzothiazole, 99% (Titr.)
| 149-30-4 |
|
3-Amino-2,6-Dimethoxypyridine Monohydrochloride, 95%
| 80789-72-6 |
|
Lithium hydride, in resealable cans, 98%
| 7580-67-8 |
|
1,4-Bis(trimethylsilyl)benzene, 98%
| 13183-70-5 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 90.000
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DS=0.7)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DS=0.9)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 250000 (DG=1.2)
| 9004-32-4 |
|
Carboxymethyl Cellulose, Sodium Salt, Average MW 700000
| 9004-32-4 |
|
Tyloxapol
| 25301-02-4 |
|
4-Vinylbenzyl chloride, stabilized with 500 ppm 4-tert-butylcatechol
| 1592-20-7 |
|
Ethyl 3-phenylglycidate, 90%
| 121-39-1 |
|
2-Methyltetrahydrofuran-3-thiol
| 57124-87-5 |
|
Bis(2-methyl-3-furyl)disulphide, 98%
| 28588-75-2 |
|
2-Methylfuran-3-thiolacetate, 80%
| 55764-25-5 |
|
2-Tetrahydrofuroic acid, 99+%(gc)
| 16874-33-2 |
|
2,2,4,4,6,6-Hexamethyl-S-trithiane
| 828-26-2 |
|
MALEIC ACID, DISODIUM SALT, HYDRATE
| 371-47-1 |
|
Neurodye Di-8-ANEPPQ
| 0-01-1 |
|
Neurodye Di-12-ANEPPQ
| 0-01-1 |
|
Neurodye Di-4-ANEPPS
| 90134-00-2 |
|
Neurodye Di-8-ANEPPS
| 157134-33-7 |
|
Thallous formate, 98% (titr.)
| 992-98-3 |
|
Neurodye FM1-84
| 0-01-1 |
|
Neurodye RH-237
| 0-01-1 |
|
Neurodye RH-421
| 107610-19-5 |
|
Neurodye RH-795
| 0-01-1 |
|
Neurodye FM1-43
| 149838-22-2 |
|
Neurodye FM4-64
| 0-01-1 |
|
Neurodye FM2-10
| 0-01-1 |
|
ISOQUINOLINE-N-OXIDE
| 1532-72-5 |
|
1,3-Dithiolane-2,4,5-trithione, oligomer
| 123399-69-9 |
|
Dess-Martin periodinane, 15 wt% solution in dichloromethane
| 75-09-2 |
|
N-BENZYLIDENE-1-NAPTHYLAMINE, 97%
| 890-51-7 |
|
2-METHOXY-1-NAPHTHALENEMETHANOL
| 40696-22-8 |
|
(S)-(+)-Ibuprofen, 99%
| 51146-56-6 |
|
2-ETHOXYNAPHTHALENE, 98%
| 93-18-5 |
|
Trifluoromethanesulphinic acid potassium salt
| 41804-89-1 |
|
5-Chlorobarbituric acid
| 19645-77-3 |
|
n-Butyl (2R,3S)-(-)-2,3-epoxybutyrate, 98%
| 0-01-1 |
|
Diethyl (2R,3R)-(-)-2,3-epoxysuccinate, 98%
| 74243-85-9 |
|
Diethyl (2S,3S)-(+)-2,3-epoxysuccinate, 98%
| 73890-18-3 |
|
Benzo(e)pyrene, 99%
| 192-97-2 |
|
|